A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,245

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

February 28, 2015

Study Completion Date

August 31, 2015

Conditions
Prostate Cancer
Interventions
DRUG

tasquinimod

Tasquinimod up to a maximum maintenance dose of 1 mg once daily, administrated orally (capsule)

DRUG

Placebo

Trial Locations (204)

Unknown

Tucson

Oxnard

Santa Monica

Santa Rosa

Wellington

Atlanta

Meridian

Melrose Park

Park Ridge

Jeffersonville

Baltimore

Rockville

Boston

Jefferson City

Las Vegas

Hackensack

Lawrenceville

Buffalo

Poughkeepsie

Concord

Durham

Raleigh

Springfield

Bala-Cynwyd

Lancaster

Pittsburgh

Myrtle Beach

Nashville

Dallas

Salt Lake City

Fairfax

Norfolk

Salem

Burien

Buenos Aires

Santa Rosa

Venado Tuerto

Camperdown

Coffs Harbour

Darlinghurst

Tweed Heads

Richmond

Subiaco

Brussels

Ghent

Kortrijk

Liège

Botucatu, Sao Paulo

Cachoeiro de Itapemirim - ES

Curitiba, Parana

Florianópolis

Juiz de Fora, Minas Gerais

Mogi Das Cruzes, Sao Paulo

Natal, Rio Grande Do Norte

Passo Fundo

Porto Alegre, RS

Rio de Janeiro

Salvador/BA

São Paulo

Volta Redonda - RJ

Pleven

Plovdiv

Sofia

Varna

Kelowna

Victoria

Brantford

North York

Oakville

Santiago

Temuco

Viña del Mar

Beijing

Chengdu

Shanghai

Shantou

Wuhan

Bogotá

Santiago de Cali

Nový Jičín

Olomouc

Prague

Ústí nad Labem

Tartu

Angers

Cannes

Marseille

Montpellier

Paris

Pierre-Bénite

Rennes

Suresnes

Cologne

Dresden

Hamburg

Mannheim

Marburg

München

Münster

Nürtingen

Tübingen

Weiden

Athens

Pátrai

Thessaloniki

Pune

Beersheba

Haifa

Jerusalem

Petah Tikva

Ramat Gan

Tel Aviv

Ẕerifin

Cremona

Lecco

Meldola

Milan

Padua

Ravenna

Roma

Torino

Liepāja

Riga

Beirut

Bsalîm

Kaunas

Vilnius

Chihuahua, Chih.

Culiacan, Sinaloa

Leon, GTO

Puebla City

Zapopan, Jalisco

Amsterdam

Groningen

Leiden

Nijmegen

Tilburg

Christchurch

Nelson

Palmerston North

Tauranga

Panama City

Arequipa

Bialystok

Lodz

Mysłowice

Poznan

Warsaw

Wroclaw

Baia Mare

Bucharest

Cluj-Napoca

Craiova

Ploieşti

Suceava

Timișoara

Moscow

Novosibirsk

Omsk

Saint Petersburg

Vladimir

Yekaterinburg

Bratislava

Trenčín

Gwangju

Seoul

Seville

Zaragoza

Santander

Sabadell

Alcorcón

Pamplona

Oviedo

Barcelona

San Sebastián de los Reyes

Valencia

Gothenburg

Karlstad

Stockholm

Kaohsiung City

Taichung

Taipei

Taoyuan District

Istanbul

Chernivtsi

Dnipropetrovsk

Donetsk

Ivano-Frankivsk

Kharkiv

Kyiv

Lutsk

Lviv

Odesa

Uzhhorod

Zaporizhzhya

Birmingham

Chichester

Leeds

London

Northwood

Nottingham

Oxford

Scunthorpe

Sutton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Active Biotech AB

INDUSTRY